• Mashup Score: 0

    The management of advanced prostate cancer (APC) has undergone some major changes in recent years from patient evaluation to treatment secondary to the addition of many new treatments to our toolbox by way of recent genetics and clinical trials. Although only 6% of our prostate cancer patients will initially present with distant disease, we know that the implications on quality of life and…

    Tweet Tweets with this article
    • #TBT: "#AUA21 COURSE: Advanced Prostate Cancer" 🔗 https://t.co/I0J5eL9fZG "We can make a meaningful impact on these patients’ overall health and maximize their quality of life." By: Rachel Hastings, MS, PA-C; Anne Calvaresi, DNP, CRNP, RNFA; and Jim Kovarik, MS, PA-C #Urology https://t.co/xtEb1dERfk

  • Mashup Score: 0

    AUA 2021 AUA guidelines, guideline update for non-muscle invasive bladder cancer, AUA guidelines muscle invasive bladder cancer, high-grade T1 disease, SWOG S0337 trial, intravesical gemcitabine versus saline immediately following TURBT.

    Tweet Tweets with this article
    • @AmerUrological Guideline Amendment: Non-muscle invasive #BladderCancer and Muscle Invasive Bladder Cancer. Presented by @JamesJmm23 @Columbia. #AUA21 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/Sf2PPn8vZR @nyphospital https://t.co/N792t9Xe7h

  • Mashup Score: 1

    AUA 2021 AUA guidelines, guideline update for non-muscle invasive bladder cancer, AUA guidelines muscle invasive bladder cancer, high-grade T1 disease, SWOG S0337 trial, intravesical gemcitabine versus saline immediately following TURBT.

    Tweet Tweets with this article
    • @AmerUrological Guideline Amendment: Non-muscle invasive #BladderCancer and Muscle Invasive Bladder Cancer. Presented by @JamesJmm23 @Columbia. #AUA21 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/Sf2PPn8vZR @nyphospital https://t.co/YeATymBF3B